The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: a systematic review and meta-analysis.
<h4>Background</h4>Several recent reports have demonstrated that tyrosine (Y)-methionine (M)-aspartic acid (D)-aspartic acid (D) (YMDD) motif mutations can naturally occur in chronic HBV patients without antiviral treatment such as lamivudine therapy. This paper aims to assess the overal...
Saved in:
Main Authors: | Youwen Tan, Keqin Ding, Jing Su, Xuan Trinh, Zhihang Peng, Yuhua Gong, Li Chen, Qian Cui, Na Lei, Xin Chen, Rongbin Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0032789&type=printable |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
QUANTITATION OF LAMIVUDINE BY UV SPECTROPHOTOMETRY
by: Y. A. Gonchikova, et al.
Published: (2017-07-01) -
C2729T mutation associated with HBV mother-to-child transmission reduces HBV production via suppressing LHBs expression
by: Minmin Liu, et al.
Published: (2023-12-01) -
Duration of untreated illness in bipolar disorder
by: Monica Macellaro, et al.
Published: (2025-09-01) -
HBV & HCV Immunopathogenesis
by: Lokhande, Megha U., et al.
Published: (2011) -
Comparative efficacy of Lamivudine and emtricitabine: a systematic review and meta-analysis of randomized trials.
by: Nathan Ford, et al.
Published: (2013-01-01)